高级检索
当前位置: 首页 > 详情页

Simvastatin accelerates hematoma resolution after intracerebral hemorrhage in a PPAR gamma-dependent manner

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, 30 Gaotanyan St, Chongqing 400038, Peoples R China [2]First Peoples Hosp Yunnan Prov, Dept Reprod & Genet, Reprod Med Ctr, Kunming 650200, Yunnan, Peoples R China
出处:
ISSN:

关键词: Intracerebral hemorrhage Simvastatin CD36 Microglia/macrophages polarization PPAR gamma Erythrophagocytosis

摘要:
To date, the neuroprotective effects of statins on intracerebral hemorrhage (ICH) are not well established. This study explored the effect and potential mechanism of simvastatin treatment on ICH. In the present study, the effects of simvastatin on hematoma absorption, neurological outcome, CD36 expression and microglia polarization were examined in rat model of ICH model. In the meantime, inhibitory effect of PPARy inhibitor GW9662 was investigated following ICH. Additionally, the effect of simvastatin on PPARy activation was also investigated in rat ICH model and primary microglia culture. Much more, the role of PPARy and CD36 in simvastatin-mediated erythrocyte phagocytosis was also detected by using in vivo or in vitro phagocytosis models, respectively. After ICH, simvastatin promoted hematoma absorption and improved neurological outcome after ICH while upregulating CD36 expression and facilitating M2 phenotype polarization in perihematomal microglia. In addition, simvastatin increased PPARy activation and reinforced microglia-induced erythrocyte phagocytosis in vivo and in vitro. All above effects of simvastatin were abolished by PPARy inhibitor GW9662. In conclusion, our data suggested that simvastatin could enhance hematoma clearance and attenuate neurological deficits possibly by activating PPARy. (C) 2017 Elsevier Ltd. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 2 区 医学
小类 | 1 区 药学 2 区 神经科学
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 药学 3 区 神经科学
JCR分区:
出版当年[2017]版:
Q1 PHARMACOLOGY & PHARMACY Q1 NEUROSCIENCES
最新[2023]版:
Q1 PHARMACOLOGY & PHARMACY Q1 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, 30 Gaotanyan St, Chongqing 400038, Peoples R China
通讯作者:
通讯机构: [1]Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, 30 Gaotanyan St, Chongqing 400038, Peoples R China [*1]Department of Neurosurgery, Southwest Hospital, Third Military Medical University, No. 30, Gaotanyan Street, Chongqing, 400038, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82490 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号